Associations of Thrombocytopenia, Transaminase Elevations, and Transfusion With Laboratory Coagulation Tests in Women With Preeclampsia: A Cross-sectional Study. Issue 2 (24th June 2022)

• Record Type: Journal Article
• Authors: Combs, D.J.; Gray, K.J.; Schulman, S.; Bateman, B.T.
• Is Part Of: Obstetric anesthesia digest. Volume 42:Issue 2(2022)
• Page Start: 83
• Page End: 84
• Publication Date: 2022-06-24
• Subjects: Preeclampsia/Eclampsia -- Obstetric Hemorrhage; Anesthesia in obstetrics -- Periodicals; Anesthesia in obstetrics -- Abstracts -- Periodicals; 617.968205
• DOI: 10.1097/01.aoa.0000827892.13946.0e
• Languages: English
• ISSNs: 0275-665X

Abstract

Abstract : ( Int J Obstet Anesth . 2021;46:102972) Preeclampsia is associated with increased incidence of thrombocytopenia (TCP) and coagulopathy, causing concern about obstetric hemorrhage [postpartum hemorrhage (PPH)] and spinal-epidural hematoma with neuraxial procedures. In the absence of other contraindications, a patient with a platelet count >70×10 9 /L and normal platelet function should be a candidate for a neuraxial procedure. Coagulation testing is not routine in preeclamptic women. Previous data and guidelines on the relationship between coagulation testing and risk of complications from neuraxial procedures are inconsistent. This study aimed to better understand the use of coagulation testing in patients with preeclampsia.